SAVA Lawsuit Alert! Class Action Against Cassava Sciences Inc.
A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The ...
How greed and profit fueled one failed Alzheimer drug
Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for ...
pharmaphorum6d
End looms for Cassava's simufilam in Alzheimer's disease
Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...
Morningstar7d
Cassava Sciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SAVA
The results indicated that simufilam failed to meet each of the ... If you suffered a loss in Cassava Sciences, Inc. during the relevant time frame, you have until February 10, 2025 to request ...
Business Insider13d
Investors who lost money on Cassava Sciences, Inc. (SAVA) should contact Levi & Korsinsky about pending Class Action - SAVA
NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal ...
Clear Creek Financial Management LLC Sells 124,541 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA)
Clear Creek Financial Management LLC lowered its stake in shares of Cassava Sciences, Inc. (NASDAQ:SAVA – Free Report) by ...
Business Wire9d
CASSAVA SCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class ...
CASSAVA SCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against ...
Stockhouse27d
Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAVA
or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...
Yahoo Finance9d
Cassava Sciences, Inc. (SAVA)
Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on Simufilam did not show a significant reduction in cognitive or functional ...
Yahoo Finance20d
Cassava Sciences, Inc. (SAVA)
Company plans to add cognition and plasma biomarker monitoring to the open-label extension trials to gather additional long-term data on simufilam treatment. AUSTIN, Texas, July 30, 2024 (GLOBE ...